CGC-601, A NOVEL beta gamma-ONLY IL-2 VARIANT, ENHANCES MODERATE IMMUNE ACTIVATION WITHOUT TREG EXPANSION, AND EXHIBITS A SUPERIOR SAFETY EVIDENCE IN VIVO
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined